MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$7,097K
Free Cash flow
-$9,476K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from issuance of pre-fu...
Maturity of investments
Others
Negative Cash Flow Breakdown
Change in the fair value of warr...
Net loss
Change in the fair value of prom...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net loss
-2,676
-10,760
-7,804
-10,998
Stock-based compensation expense
1,101
622
625
1,724
Depreciation
14
5
12
29
Change in the fair value of warrant liability
-6,700
5,400
1,600
-1,777
Transaction costs associated with warrants
-
0
0
0
Change in the fair value of promissory note
-500
800
400
-423
Promissory note issuance costs
0
0
-1
-335
Gain on sale of equipment
31
-
-
-
Accretion of discount on short-term investments
4
38
89
218
Change in unrealized losses on investments
-
1
-
-
Prepaid expenses, other current and non-current assets
337
-255
-292
11
Accounts payable
-113
44
-796
-88
Accrued expenses and other liabilities
-230
-1,179
981
-121
Net cash used in operating activities
-9,476
-4,852
-4,778
-11,548
Purchase of investments
0
496
1,480
13,940
Maturity of investments
1,500
7,650
5,000
12,845
Purchases of property and equipment
0
6
8
14
Proceeds from sale of fixed assets
42
-
-
-
Net cash provided by (used in) investing activities
1,542
7,148
3,512
-1,109
Proceeds from issuance of common stock
12,000
0
0
8
Proceeds from exercise of stock options
-
0
25
0
Proceeds from issuance of pre-funded warrants
3,000
-
-
-
Proceeds from issuance of promissory note, net
0
0
0
9,664
Proceeds from issuance of common stock from atm facility, net of issuance costs
31
3,754
793
968
Net cash provided by financing activities
15,031
3,754
818
10,640
Net increase (decrease) in cash and cash equivalents
7,097
6,050
-448
-2,017
Cash and cash equivalents at beginning of period
11,520
5,470
7,935
-
Cash and cash equivalents at end of period
18,617
11,520
5,470
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock
$12,000K
(149900.00%↑ Y/Y)
Proceeds from issuance of
pre-funded warrants
$3,000K
Proceeds from issuance of
common stock from atm...
$31K
(-96.80%↓ Y/Y)
Maturity of investments
$1,500K
(-88.32%↓ Y/Y)
Proceeds from sale of
fixed assets
$42K
Net cash provided by
financing activities
$15,031K
(41.27%↑ Y/Y)
Net cash provided by
(used in) investing...
$1,542K
(239.04%↑ Y/Y)
Net increase
(decrease) in cash and cash...
$7,097K
(451.86%↑ Y/Y)
Canceled cashflow
$9,476K
Stock-based compensation
expense
$1,101K
(-36.14%↓ Y/Y)
Depreciation
$14K
(-51.72%↓ Y/Y)
Net cash used in
operating activities
-$9,476K
(17.94%↑ Y/Y)
Canceled cashflow
$1,115K
Change in the fair value
of warrant...
-$6,700K
(-277.04%↓ Y/Y)
Net loss
-$2,676K
(75.67%↑ Y/Y)
Change in the fair value
of promissory note
-$500K
(-18.20%↓ Y/Y)
Prepaid expenses, other
current and non-current...
$337K
(2963.64%↑ Y/Y)
Accrued expenses and
other liabilities
-$230K
(-90.08%↓ Y/Y)
Accounts payable
-$113K
(-28.41%↓ Y/Y)
Gain on sale of
equipment
$31K
Accretion of discount on
short-term investments
$4K
(-98.17%↓ Y/Y)
Buy us a coffee
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)